v3.26.1
Convertible Preferred Stock and Stockholders’ Equity (Tables)
6 Months Ended
Jun. 30, 2026
Convertible Preferred Stock and Stockholders’ Equity [Abstract]  
Schedule of Outstanding Warrants

The following summarizes the Company’s outstanding warrants, excluding contingent warrants issuable upon exercise of the outstanding warrants as of June 30, 2026:

 

    Number of
Shares
    WA
Average
Exercise
Price
    WA
Remaining
Contractual
Life
(in years)
 
Outstanding as of December 31, 2025     24,608,745       248.50       2.73  
Granted                  
Exercised     (396,090 )            
Cancelled                  
Outstanding as of March 31, 2026     24,212,655       262.55       2.49  
Granted                  
Exercised                  
Cancelled                  
Outstanding as of June 30, 2026     24,212,655       1.27       2.24  
Warrants vested and exercisable as of June 30, 2026     24,212,655       1.27       2.24  
Schedule of Restricted Stock

The following summarizes activity related to the Company’s restricted stock awards granted under the 2022 Plan for the six months ended June 30, 2026:

 

          Weighted  
          Average  
    Number of     Grant Date  
    Shares     Fair Value  
Nonvested as of December 31, 2025     39     $ 715.50  
Granted            
Vested            
Forfeited     (13 )     986.20  
Nonvested as of March 31, 2026     26     $ 579.20  
Granted            
Vested            
Forfeited     (26 )     579.20  
Nonvested as of June 30, 2026         $  
Schedule of Stock-Based Compensation Expense

Stock-based compensation expense related to stock options and restricted stock, for the three and six months ended June 30, 2026 and 2025 was as follows:

 

    For the Three Months Ended
June 30,
 
    2026     2025  
Selling, general and administrative   $ 7,359     $ 30,982  
Research and development            
Total   $ 7,359     $ 30,982  

 

    For the Six Months Ended
June 30,
 
    2026     2025  
Selling, general and administrative   $ 29,664     $ 60,238  
Research and development            
Total   $ 29,664     $ 60,238